Skip to content
drillr.ai
Sign up

ROIV

Roivant Sciences Ltd.

NASDAQ · Healthcare · Biotechnology · GB

$34.93
+1.51%
Ask drillr
0
Insider buys (3m)
31
Insider sells (3m)
-$223.4M
Net value (3m)
+20.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 1, 2026Venker Eric · officer: President & Immunovant CEOSale33,818$36
Sep 1, 2026Venker Eric · officer: President & Immunovant CEOSale166,182$36
Sep 1, 2026Venker Eric · officer: President & Immunovant CEOM-Exempt200,000$3.85
Aug 24, 2026Pulik Richard · officer: CFOF-InKind5,749$37
Aug 24, 2026Venker Eric · officer: President & Immunovant CEOF-InKind13,909$37
Aug 21, 2026Sukhatme Mayukh · director, officer: President & CIOSale17,519$37
Aug 21, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt172,899$3.85
Aug 21, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt144,756$3.85
Aug 21, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt17,519$3.85
Aug 21, 2026Sukhatme Mayukh · director, officer: President & CIOSale172,899$37
Aug 21, 2026Sukhatme Mayukh · director, officer: President & CIOSale144,756$36
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt243,177$3.85
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt105,141$3.85
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt136,942$3.85
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOSale31,801$37
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOSale105,141$37
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt284,707$3.85
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOSale284,707$36
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOSale243,177$36
Aug 18, 2026Sukhatme Mayukh · director, officer: President & CIOM-Exempt31,801$3.85
Jul 29, 2026Venker Eric · officer: President & Immunovant CEOSale200,000$35
Jul 29, 2026Venker Eric · officer: President & Immunovant CEOM-Exempt200,000$3.85
Jul 21, 2026MOMTAZEE JAMES C · directorA-Award405$0.00
Jul 21, 2026Epperly Melissa B, · directorA-Award543$0.00
Jul 21, 2026Oren Ilan · directorA-Award775$0.00
Jul 2, 2026Sukhatme Mayukh · director, officer: President & CIOF-InKind46,878$35
Jul 2, 2026Fitzgerald Meghan · directorSale10,000$35
Jul 2, 2026Torti Frank · officer: President and Vant ChairF-InKind40,310$35
Jul 2, 2026Gline Matthew · director, officer: CEOF-InKind76,171$35
Jul 2, 2026Fitzgerald Meghan · directorM-Exempt10,000$8.80
Institutional positioning

13F filings over the trailing two quarters

New 191Increased 375Reduced 271Sold out 43
FilerActionSharesFiled
FMR LLCIncreased81,020,390Aug 13, 2026
FMR LLCIncreased77,981,253May 15, 2026
MORGAN STANLEYReduced51,828,325May 15, 2026
BlackRock, Inc.Increased48,236,091Aug 7, 2026
BLACKROCK, INC.Increased44,254,260May 13, 2026
MORGAN STANLEYReduced42,592,905Aug 13, 2026
QVT FINANCIAL LPReduced25,161,237May 15, 2026
QVT Financial LPReduced23,723,074Aug 14, 2026
UBS GROUP AGIncreased22,619,472May 5, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased22,123,198Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased21,641,339Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position20,680,572May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position19,838,698May 8, 2026
GOLDMAN SACHS GROUP INCIncreased18,556,458Aug 14, 2026
STATE STREET CORPIncreased17,795,975Aug 7, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026